Clinical Case Reports (Apr 2021)

Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report

  • Yuki Ikeda,
  • Michihiro Ono,
  • Ginji Ohmori,
  • Saki Ameda,
  • Michiko Yamada,
  • Tomoyuki Abe,
  • Shigeyuki Fujii,
  • Miri Fujita,
  • Masahiro Maeda

DOI
https://doi.org/10.1002/ccr3.4008
Journal volume & issue
Vol. 9, no. 4
pp. 2259 – 2263

Abstract

Read online

Key Clinical Message The tumor reduction effect of pembrolizumab is extremely high compared to standard chemotherapy and might show prolonged survival. Therefore, the MSI status should be examined in patients with cholangiocarcinoma.

Keywords